TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33964828

Group type: EXPERIMENTAL
Intervention: Combined eradication and prokinetic therapy (itoprid hydrochloride 50 mg three times a day)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Eradication therapy only
Number of subjects: 126
Study: 34432984

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for tinnitus
Number of subjects: 27
Study: 33244081

Group type: EXPERIMENTAL
Intervention: Facial and bodily movements available
Number of subjects: 140

Group type: COMPARATOR
Intervention: Only facial movements available
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Bodily movements available
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Machine learning classifiers for nonverbal cues
Number of subjects: 140
Study: 35640310

Group type: EXPERIMENTAL
Intervention: CALM (computer-facilitated CBT intervention)
Number of subjects: 961

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 961
Study: 32318057

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (THG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (THG) in high-risk patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: ATG-Fresenius (ATG-F)
Number of subjects: 27
Study: 32687434

Group type: EXPERIMENTAL
Intervention: Integrative Body Mind Spirit (I‐BMS) intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study: 34104419

Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32227108

Group type: EXPERIMENTAL
Intervention: Music therapy clinicians' involvement in research
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Support from a mentor, supervisor, and/or administrator
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Seeking out available resources
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Knowing roles and responsibilities
Number of subjects: 10
Study: 33966955

Group type: EXPERIMENTAL
Intervention: Diagnostic findings plus education about additional genomic findings and the option to request them (DF + EAF)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Diagnostic findings only (DF)
Number of subjects: 335
Study: 35978377

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) intervention for 72 weeks
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 216
Study: 32093652

Group type: EXPERIMENTAL
Intervention: Ketotifen Fumarate (KF) 2 mg or 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 0
Study: 35442497

Group type: EXPERIMENTAL
Intervention: Essence of chicken (EOC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 34
Study: 33798312

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Heixiaoyao powder
Number of subjects: 180

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 180

Group type: COMPARATOR
Intervention: Heixiaoyao powder
Number of subjects: 180
Study: 35569833

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32441408

Group type: EXPERIMENTAL
Intervention: High-intensity training in normobaric hypoxia (HYP; 15.0% inspired O2)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-intensity training in normoxia (NOR; 20.9% inspired O2)
Number of subjects: 8
Study: 34312798

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg/day
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide fumarate (TAF) 25 mg/day
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both TAF and TDF
Number of subjects: 72
Study: 32816829

Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation (starting within 2 weeks after an exacerbation)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard treatment (same programme starting 2 months later)
Number of subjects: 70
Study: 32855275

Group type: EXPERIMENTAL
Intervention: CS-AML
Number of subjects: 413

Group type: COMPARATOR
Intervention: sAML
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Allogeneic transplant in first complete remission
Number of subjects: 413
Study: 32149451

Group type: EXPERIMENTAL
Intervention: Sodium zirconium cyclosilicate (SZC) 10 g
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35998955

Group type: EXPERIMENTAL
Intervention: Oat beta-glucan-enriched bread
Number of subjects: 250

Group type: COMPARATOR
Intervention: Whole-grain wheat bread
Number of subjects: 250
Study: 34750392

Group type: EXPERIMENTAL
Intervention: Adjuvant gefitinib
Number of subjects: 171

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Adjuvant gefitinib or chemotherapy based on genomic profiling
Number of subjects: 171
Study: 33774886

Group type: EXPERIMENTAL
Intervention: E-cigarettes
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Nicotine e-cigarettes
Number of subjects: 607
Study: 32675536

Group type: EXPERIMENTAL
Intervention: Sutures
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Nonabsorbable mesh
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sutures and Nonabsorbable mesh
Number of subjects: 126
Study: 37245533

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (20 IU, twice/day) with dulaglutide (1.5 mg/week)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intranasal placebo with dulaglutide (1.5 mg/week)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intranasal insulin (20 IU, twice/day) with placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intranasal placebo with placebo
Number of subjects: 80
Study: 34302899

Group type: EXPERIMENTAL
Intervention: Parental qualities (general parenting styles, parent feeding practices, and parental BMI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Structure in general parenting
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parental feeding practice
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coercive control general parenting
Number of subjects: 50
Study: 32943059

Group type: EXPERIMENTAL
Intervention: Colon capsule endoscopy (CCE)
Number of subjects: 349

Group type: COMPARATOR
Intervention: CT colonography (CTC)
Number of subjects: 349
Study: 33188428

Group type: EXPERIMENTAL
Intervention: Increased IL-17 levels (genetically predicted)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: C allele of rs117556572
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: TNF-α, IL-12p70, decreased IL-17 levels
Number of subjects: 900
Study: 33581015

Group type: EXPERIMENTAL
Intervention: Metformin therapy (MT) group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Insulin therapy (IT) group
Number of subjects: 60
Study: 32669140

Group type: EXPERIMENTAL
Intervention: High protein group (≥2·2 g/kg per d) receiving combined enteral and parenteral nutrition (EN+PN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low protein group (≤1·2 g/kg per d) receiving enteral nutrition (EN) alone
Number of subjects: 0
Study: 35233478

Group type: EXPERIMENTAL
Intervention: 1 egg/d for 6 months
Number of subjects: 660

Group type: COMPARATOR
Intervention: Nonintervention control
Number of subjects: 660
Study: 32174340

Group type: EXPERIMENTAL
Intervention: Pushing an industrial trolley at different speed values and load conditions
Number of subjects: 96
Study: 34923339

Group type: EXPERIMENTAL
Intervention: Mori ramulus (MR) extract
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33231873

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus best supportive care (BSC)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 398
Study: 33935686

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Both HIIT and MCT
Number of subjects: 128
Study: 32651307

Group type: EXPERIMENTAL
Intervention: IPostC
Number of subjects: 60

Group type: COMPARATOR
Intervention: IPostC+GA
Number of subjects: 60
Study: 33392802

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF) applied locally at the surgical site after necrotic bone removal.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group received traditional surgical therapy with primary closure of the surgical area.
Number of subjects: 28
Study: 33032612

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) as first lung image
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest X-ray (CXR) as first pulmonary image
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LUS or CXR not suggestive of BN and PCT > 1 ng/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LUS or CXR not suggestive of BN and PCT < 1 ng/mL
Number of subjects: 0
Study: 35401783

Group type: EXPERIMENTAL
Intervention: Touch combined with intelligent interactive nursing mode of voice, music, and rhythm
Number of subjects: 140

Group type: COMPARATOR
Intervention: Touch nursing
Number of subjects: 140
Study: 33624417

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32456877

Group type: EXPERIMENTAL
Intervention: SSPNJH (Niño Jesús Hospital procedural sedation-analgesia scale)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SSPNJH
Number of subjects: 65
Study: 35254932

Group type: EXPERIMENTAL
Intervention: Peer comparison feedback
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Combination of peer comparison and individual audit feedback
Number of subjects: 263

Group type: COMPARATOR
Intervention: Individual audit feedback
Number of subjects: 263

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 263
Study: 32084347

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 80
Study: 33554701

Group type: EXPERIMENTAL
Intervention: Virtual scenario simulation combined with problem-based learning (PBL)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional teaching methods
Number of subjects: 300
Study: 33267837

Group type: EXPERIMENTAL
Intervention: Oral clonazepam (0.05 mg/Kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral lorazepam (0.05 mg/Kg)
Number of subjects: 30
Study: 36215079

Group type: EXPERIMENTAL
Intervention: Transcatheter PFO closure plus antithrombotic therapy
Number of subjects: 3740

Group type: COMPARATOR
Intervention: Antithrombotic therapy alone
Number of subjects: 3740
Study: 32869214

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 35081482

Group type: EXPERIMENTAL
Intervention: Low Intolerance of Uncertainty (LIU) manipulation
Number of subjects: 106

Group type: COMPARATOR
Intervention: High Intolerance of Uncertainty (HIU) manipulation
Number of subjects: 106
Study: 34877622

Group type: EXPERIMENTAL
Intervention: Active rTMS (1-Hz, 110% RMT, 5 × 60 s trains)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 54

Group type: COMPARATOR
Intervention: Active rTMS and Sham rTMS
Number of subjects: 54
Study: 34197791

Group type: EXPERIMENTAL
Intervention: Vivifrail tailored, multicomponent exercise program (24 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vivifrail tailored, multicomponent exercise program (4 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Detraining after 24 weeks of training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vivifrail training
Number of subjects: 24
Study: 32473534

Group type: EXPERIMENTAL
Intervention: Animal-assisted intervention (AAI)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Non-animal-assisted intervention (non-AAI)
Number of subjects: 5
Study: 35141030

Group type: EXPERIMENTAL
Intervention: Video education (N = 120)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No video education (N = 120)
Number of subjects: 240
Study: 34519832

Group type: EXPERIMENTAL
Intervention: risedronate + CaD
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: bone-loading exercises + CaD
Number of subjects: 276

Group type: COMPARATOR
Intervention: calcium and vitamin D supplements (CaD)
Number of subjects: 276
Study: 33745203

Group type: EXPERIMENTAL
Intervention: Football with diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Football-only
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet-only
Number of subjects: 40
Study: 33162978

Group type: EXPERIMENTAL
Intervention: GAD‐alum injection (4 μg) into lymph nodes + oral Vitamin D (2000 U/d)
Number of subjects: 12
Study: 35531985

Group type: EXPERIMENTAL
Intervention: Early childhood IPV exposure (i.e., threat)
Number of subjects: 249
Study: 34057153

Group type: EXPERIMENTAL
Intervention: Drowning scenario
Number of subjects: 20

Group type: COMPARATOR
Intervention: Burial scenario
Number of subjects: 20
Study: 34570008

Group type: EXPERIMENTAL
Intervention: Technology-based program
Number of subjects: 115
Study: 32828678

Group type: EXPERIMENTAL
Intervention: Amoxicillin alone (70 mg/kg) for five days
Number of subjects: 129

Group type: COMPARATOR
Intervention: Amoxicillin (70 mg/kg) plus clarithromycin (15 mg/kg) for the initial three days
Number of subjects: 129
Study: 34358811

Group type: EXPERIMENTAL
Intervention: One-view mediolateral (MLO) DM-DBT
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: One-view craniocaudal (CC) DM-DBT
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Two-view DM-DBT
Number of subjects: 138

Group type: COMPARATOR
Intervention: CC DM-DBT view
Number of subjects: 138

Group type: COMPARATOR
Intervention: MLO DM-DBT view
Number of subjects: 138
Study: 33022713

Group type: COMPARATOR
Intervention: Vitamin D (1000 IU/d)
Number of subjects: 2259

Group type: COMPARATOR
Intervention: Calcium (1200 mg/d)
Number of subjects: 2259

Group type: COMPARATOR
Intervention: Both vitamin D and calcium
Number of subjects: 2259
Study: 34841554

Group type: EXPERIMENTAL
Intervention: mHealth intervention (GoShare bundles) provided preoperatively, at one week post-discharge, and 30 days after surgery.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (in-patient discharge education and local paper-based written discharge materials).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mHealth intervention (GoShare bundles).
Number of subjects: 0
Study: 33009445

Group type: EXPERIMENTAL
Intervention: Toe pulse arrival time (PAT) via PPG foot
Number of subjects: 32

Group type: COMPARATOR
Intervention: Other conventional pulse transit times (cPTTs) including finger PAT
Number of subjects: 32
Study: 36189594

Group type: EXPERIMENTAL
Intervention: Optimal time of day (morning)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Non-optimal time of day (evening)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 106
Study: 32324509

Group type: EXPERIMENTAL
Intervention: Sucrose; stored at 4°C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sucrose-free chocolate; stored at 4°C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control chocolate (not specified); stored at 20°C
Number of subjects: 0
Study: 35078875

Group type: EXPERIMENTAL
Intervention: Video Decision Support Tool (VDST)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 113
Study: 33515998

Group type: EXPERIMENTAL
Intervention: Phytase supplementation (1 000 U/kg diet) with 1.0, 1.5, or 2.0 g/kg NPP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (phytase-absent) with 2.0, 2.5, or 3.0 g/kg NPP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Phytase supplementation
Number of subjects: 48
Study: 32510734

Group type: EXPERIMENTAL
Intervention: Single 1.2-g dose of oral azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial adult dose of 500 mg followed by 250 mg per day for 4 days (total cumulative dose of 1.5 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: For children aged 5 to 18 years, 10 mg/kg on the first day followed by 5 mg/kg for 4 days
Number of subjects: 0
Study: 35397826

Group type: EXPERIMENTAL
Intervention: Single session treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Weekly treatment
Number of subjects: 53
Study: 34393215

Group type: EXPERIMENTAL
Intervention: PEM block education session
Number of subjects: 45
Study: 32887411

Group type: EXPERIMENTAL
Intervention: Combined training program (CTP) of strength exercises and cognitive–motor tasks for 24 weeks, 3 sessions per week
Number of subjects: 31
Study: 33794708

Group type: EXPERIMENTAL
Intervention: Short-axis ultrasound guided technique
Number of subjects: 283

Group type: COMPARATOR
Intervention: Long-axis ultrasound guided technique
Number of subjects: 283
Study: 33826205

Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention (part of the SUPERB trial)
Number of subjects: 20
Study: 34117375

Group type: COMPARATOR
Intervention: Pomegranate juice (PJ)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Direct supplementation with Urolithin A (500 mg)
Number of subjects: 100
Study: 33822361

Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine
Number of subjects: 432
Study: 32673736

Group type: EXPERIMENTAL
Intervention: Tertile 3 facilities (highest percentage of Black residents)
Number of subjects: 4567

Group type: COMPARATOR
Intervention: Tertile 1 facilities (lowest percentage of Black residents)
Number of subjects: 4567
Study: 36149331

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bi-07 (2 × 10^12 CFU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactase (4662 FCC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33428638

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control healthy living course
Number of subjects: 0
Study: 32942424

Group type: EXPERIMENTAL
Intervention: Pore-by-pore modeling with optimized contact angle adjustments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomly assigned distributions of contact angle
Number of subjects: 0
Study: 35472672

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg daily
Number of subjects: 15081

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15081
Study: 32167978

Group type: EXPERIMENTAL
Intervention: S-ketamine 0.12 mg/kg/h
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: S-ketamine 0.6 mg/kg/h
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%)
Number of subjects: 198
Study: 35662230

Group type: EXPERIMENTAL
Intervention: Compression therapy (not specified dosage or duration)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard postoperative wound management pathway (details not specified)
Number of subjects: 58
Study: 33069511

Group type: COMPARATOR
Intervention: Basmati rice (CONTROL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Boiled potato (BOIL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Roasted potato (ROAST)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Boiled potato cooled for 24 hours (COOLED)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All potato meals
Number of subjects: 24
Study: 36225251

Group type: EXPERIMENTAL
Intervention: ESPB group (preoperative ultrasound‐guided lumbar ESPB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (spinal alone)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: ESPB group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 33326257

Group type: EXPERIMENTAL
Intervention: Capivasertib (320 mg twice daily, 4 days on/3 days off)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Capivasertib and Placebo
Number of subjects: 150
Study: 34702621

Group type: EXPERIMENTAL
Intervention: aTIV
Number of subjects: 424

Group type: COMPARATOR
Intervention: QIV
Number of subjects: 424
Study: 35920686

Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 394
Study: 32860422

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + oral antidepressant (AD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: AD + placebo
Number of subjects: 100
Study: 33838678

Group type: EXPERIMENTAL
Intervention: Parent Positive
Number of subjects: 616

Group type: COMPARATOR
Intervention: Follow-up As Usual (FAU)
Number of subjects: 616
Study: 33169306

Group type: EXPERIMENTAL
Intervention: RCC < 2 cm
Number of subjects: 43147

Group type: COMPARATOR
Intervention: RCC 2.1–4 cm
Number of subjects: 43147
Study: 32795428

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (Mirena)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Endometrial ablation (NovaSure)
Number of subjects: 270
Study: 32195937

Group type: EXPERIMENTAL
Intervention: Supervised physical exercise program (aerobic and resistance training), 48 sessions over 16 weeks (3 sessions/week, 60 min/session)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Supervised physical exercise program (aerobic and resistance training)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle recommendations (Control group)
Number of subjects: 40
Study: 34811807

Group type: EXPERIMENTAL
Intervention: Depressive symptomatology (PHQ‐9 score ≥ 10)
Number of subjects: 3356

Group type: EXPERIMENTAL
Intervention: Subthreshold depressive symptomatology (PHQ‐9 score 5‐9 and at least one core depressive symptom)
Number of subjects: 3356

Group type: COMPARATOR
Intervention: Female gender, low socioeconomic conditions, and presence of chronic conditions
Number of subjects: 3356

Group type: COMPARATOR
Intervention: Female gender and having hypertension
Number of subjects: 3356
Study: 36066336

Group type: EXPERIMENTAL
Intervention: Turmeric mouthwash
Number of subjects: 92

Group type: COMPARATOR
Intervention: Benzydamine mouthwash
Number of subjects: 92
Study: 33537844

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32433790

Group type: EXPERIMENTAL
Intervention: Near-focus narrowband imaging (NF‐NBI)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Indigo carmine chromoendoscopy (ICC)
Number of subjects: 395
Study: 35759637

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (1 g)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Subcutaneous tranexamic acid (1 g)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 141